How Your Brain’s Reward Circuits Drive Your Choices | Dr. Robert Malenka

Guest
Dr. Robert Malenka
Read time
~4 min
Uploaded
10 Jul 2023
Duration
2:50:03
Views
1.2M
OPEN ON YOUTUBE ↗

KEYPOINTS

  • 01

    The reward circuit evolved to tag what matters for survival

    Malenka, a Stanford psychiatrist and neuroscientist, describes dopamine neurons in the ventral tegmental area (VTA) projecting to the nucleus accumbens. This system marks food, water, sex and social contact as worth pursuing again. Drugs of abuse 'trick' it into treating an experience as vital for survival, which is why they can generate such compulsive repetition.

  • 02

    Route of administration drives addictive liability

    You can't become addicted to something you never take, and how you take it matters. Smoking or injecting cocaine or methamphetamine gets the drug into the brain almost instantly and produces a rapid, powerful dopamine surge in the accumbens lasting seconds to minutes. Malenka links this to the crack epidemic and today's meth crisis. He notes our brains didn't evolve to handle drugs that potent, or synthetic opioids like fentanyl.

  • 03

    Drugs remodel reward synapses using normal learning machinery

    Work from Malenka's lab and others shows cocaine, methamphetamine, morphine and heroin cause powerful plasticity at synapses onto dopamine neurons and accumbens neurons. The changes resemble those used in adaptive learning and memory. The circuit is highly plastic and can become sensitized to particular experiences.

  • 04

    Who becomes addicted is a mix of genes and environment

    Many people use a substance without developing a problem. Malenka attributes the difference to genetics, current environment and the environment you grew up in, all of which shape the reward circuitry. Availability of a substance in a society also strongly shapes which addictions become widespread.

  • 05

    Reinforcing is not the same as rewarding; wanting is not liking

    Something is reinforcing if it makes you repeat the behavior, and rewarding if it actually feels good. Kent Berridge and Terry Robinson's 'wanting versus liking' distinction explains a friend's description of cocaine: 'I hate it, but I want to do it again.' The same pattern shows up in destructive relationships. Huberman suggests 12-step programs may work partly by building a liking for sobriety that outcompetes the wanting.

  • 06

    Cues tied to powerful experiences can trigger cravings for decades

    Because reward circuitry is closely linked to memory, places and contexts become reinforcing in their own right. Malenka tells of smoking for a few weeks in Paris at around 20, then not smoking after returning home. Forty years later, he still craves a cigarette every time he goes back to Paris.

  • 07

    Oxytocin and serotonin make social interaction reinforcing

    Building on decades of prairie vole work by Larry Young and Tom Insel showing that oxytocin in the accumbens supports pair bonding, Malenka's lab found oxytocin there promotes sociability in mice by triggering serotonin release. Oxytocin also modulates dopamine neurons in the VTA. Malenka acknowledges a recent paper questioned oxytocin's role in pair bonding, and urges weighing it against 30 years of contrary evidence and its own methodological limits.

  • 08

    MDMA's pro-social and addictive effects may use different systems

    MDMA reverses the serotonin and dopamine transporters, the 'vacuum cleaners' that normally clear these molecules, so they pump the molecules out. It favors serotonin roughly 70/30 or 80/20. Malenka's hypothesis, supported so far in mouse empathy models, is that its addictive liability runs mostly through dopamine while its pro-social and empathogenic effects run through serotonin, notably the 5-HT1B receptor in the accumbens.

  • 09

    Gambling is uniquely tied to hope

    Casinos employ people to tune slot-machine payout schedules for maximum return visits. Huberman relays a gambling addict's insight: unlike an alcoholic or cocaine user, a gambler believes the next bet could change everything for the better.

EXAMPLES

  • 01

    Bystander mice catch pain

    In work published in Science with Monique Smith (now at UC San Diego), an uninjured 'bystander' mouse that spent one hour with a mouse in modest hind-paw pain then showed pain behaviors itself for roughly 4–20 hours. Smell is likely part of the signal: bedding from mice in pain had a similar effect. Malenka calls these assays behavioral antecedents of empathy.

  • 02

    Social transfer of pain relief

    When two mice were in pain and one received morphine, the untreated mouse that spent time with the now pain-free one also showed analgesia. Malenka relates this to the human idea of social buffering of pain: his own neck pain bothers him less when he's socially engaged.

  • 03

    R- versus S-MDMA

    MDMA comes in two mirror-image forms. Other labs' work suggests S-MDMA interacts more with dopamine and R-MDMA more with serotonin. MindMed, on whose scientific advisory board Malenka sits (he disclosed this), is preparing a trial of one form for sociability deficits. MAPS, founded by Rick Doblin, has run small MDMA studies in high-functioning people with social anxiety.

  • 04

    Huberman's own MDMA trial participation

    Huberman says he participated in an MDMA trial and found it very pleasant. He stresses it isn't for everyone and remains a Schedule I drug, so possessing or selling it can lead to prison.

OTHER RELEVANT

  • 01

    Respect how fast-acting a drug or behavior is

    The faster and bigger the dopamine hit, as with smoking, injecting or highly engineered products like cigarettes and slot machines, the higher the addictive liability. Abstaining from first exposure is the one guaranteed protection.

  • 02

    Expect cue-triggered cravings and plan for them

    Places, people and routines linked to past use can provoke cravings years later. Anticipating these triggers, rather than being surprised by them, is part of staying abstinent.

  • 03

    Build rewards around the alternative

    Because wanting and liking can be pulled apart, recovery approaches that make sobriety or the new behavior genuinely enjoyable may weaken the pull of the old one.

  • 04

    Treat psychedelic and MDMA therapy with cautious optimism

    Malenka is excited by these drugs as powerful probes and potential therapies acting on specific receptors: 16 serotonin receptor types, 2A for psilocybin and LSD, 1B for MDMA's social effects. He urges appropriate caution, rigorous trials and respect for current legal status.

  • 05

    On autism language

    Malenka argues for respecting adults who don't want to be labeled as having a brain disorder, while recognizing that many children, some severely impaired, need help and research. His suggestion is to ask people what they prefer.